Physician profile
David Bieber
NPI 1972910404
$1,792.37
in general payments reported to CMS, 2019-2025
10 companies · $822 in 2025
The $822 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $315 · 2024: $655 · 2025: $822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,776 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,775.65 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $473.28 | 2024-2025 | |
| Medtronic, INC. | $407.00 | 2025 | Percept Pc Brainsense |
| Livanova USA, INC. | $303.65 | 2023-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Neurelis, INC. | $131.57 | 2023 | Valtoco |
| Neuropace, INC. | $128.88 | 2024 | |
| Insightec,INC | $104.79 | 2025 | Exablate |
| Biocodex, INC. | $84.74 | 2024 | |
| Abbott Laboratories | $83.42 | 2023 | Infinity |
| Ucb, INC. | $58.32 | 2023 | Briviact |
| Catalyst Pharmaceuticals, INC. | $16.72 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bieber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.